Hong Kong–listed Tian An Medicare Limited executed and completed a significant share repurchase on 10 June 2026. The company bought back and immediately cancelled 70.00 million ordinary shares at a volume-weighted average price of HKD 1.10 per share, for a total consideration of approximately HKD 77.00 million.

Following the cancellation, Tian An Medicare’s outstanding share capital fell to 1.01 billion shares from 1.08 billion shares, a reduction of 6.48%. No treasury shares were held before or after the transaction.

The disclosure was made under Hong Kong Stock Exchange Main Board Rule 13.25A, with the company’s latest Next Day Disclosure Return confirming that no additional repurchased shares remain pending cancellation.